Home hover Guidelines hover Expert hover Compare hover Faq hover Submit hover About hover Resources hover Syntheses hover Myngc hover Guidelinematrix hover
Home
Browse Guidelines
Expert Commentaries
Guideline Syntheses
Guideline Matrix
Guideline Resources
Compare Guidelines
Frequently Asked Questions
Submit Guidelines
About
myNGC
< Back

'hydroxymethylglutaryl-coa reductase inhibitors'
Run an advanced search on this term

Search within:  

Sort results by:      



Filter results by:

1-20 of 70   Next >
 
1.  
2.  
VA/DoD clinical practice guideline for the management of dyslipidemia for cardiovascular risk reduction. 2001 Dec (revised 2014 Dec). NGC:010627
Department of Defense - Federal Government Agency [U.S.]; Department of Veterans Affairs - Federal Government Agency [U.S.]; Veterans Health Administration - Federal Government Agency [U.S.]. View all guidelines by the developer(s)
3.  
The Clinical Pharmacogenetics Implementation Consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update. 2012 Jul (revised 2014 Oct). NGC:010590
Clinical Pharmacogenetics Implementation Consortium - Independent Expert Panel. View all guidelines by the developer(s)
5.  
Chronic kidney disease. Early identification and management of chronic kidney disease in adults in primary and secondary care. 2008 Sep (revised 2014 Jul). NGC:010500
National Clinical Guideline Centre - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
6.  
Diagnosis and management of type 2 diabetes mellitus in adults. 1996 Mar (revised 2014 Jul). NGC:010548
Institute for Clinical Systems Improvement - Nonprofit Organization. View all guidelines by the developer(s)
7.  
8.  
Screening and management of lipids. 2000 May (revised 2014 May). NGC:010399
University of Michigan Health System - Academic Institution. View all guidelines by the developer(s)
9.  
Secondary prevention of ischemic heart disease and stroke in adults. 2009 Mar (revised 2014 May). NGC:010417
University of Michigan Health System - Academic Institution. View all guidelines by the developer(s)
11.  
12.  
KDIGO clinical practice guideline for lipid management in chronic kidney disease. 2013 Nov. NGC:010184
Kidney Disease: Improving Global Outcomes - Nonprofit Organization. View all guidelines by the developer(s)
13.  
Lipid management in adults. 1997 Oct (revised 2013 Nov). NGC:010215
Institute for Clinical Systems Improvement - Nonprofit Organization. View all guidelines by the developer(s)
14.  
MI - secondary prevention. Secondary prevention in primary and secondary care for patients following a myocardial infarction. 2007 May (revised 2013 Nov). NGC:010185
National Clinical Guideline Centre - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
15.  
COPD – chronic obstructive pulmonary disease. In: Pulmonary (acute & chronic). 2009 Jan (revised 2013 Oct 29). NGC:010110
Work Loss Data Institute - For Profit Organization. View all guidelines by the developer(s)
16.  
Screening and management of hypercholesterolemia. 2003 Aug (revised 2013 Aug). NGC:010040
Michigan Quality Improvement Consortium - Professional Association. View all guidelines by the developer(s)
17.  
Stable coronary artery disease. 1994 Jul (revised 2013 May). NGC:009899
Institute for Clinical Systems Improvement - Nonprofit Organization. View all guidelines by the developer(s)
19.  
Management of diabetes mellitus. 2004 Jul (revised 2013 Mar). NGC:009934
Michigan Quality Improvement Consortium - Professional Association. View all guidelines by the developer(s)
1-20 of 70   Next >